Integrated BioPharma Inc. (OTCMKTS:INBP) Sees Significant Growth in Short Interest

Integrated BioPharma Inc. (OTCMKTS:INBP) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 509 shares, an increase of 12,625.0% from the September 30th total of 4 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 30,205 shares, the short-interest ratio is presently 0.0 days.

Integrated BioPharma Stock Performance

Integrated BioPharma stock traded down $0.01 during midday trading on Monday, hitting $0.17. 2,675 shares of the company’s stock were exchanged, compared to its average volume of 11,833. Integrated BioPharma has a 52-week low of $0.14 and a 52-week high of $0.42. The company has a market cap of $5.27 million, a P/E ratio of -1.70 and a beta of 0.50. The stock has a 50-day moving average price of $0.18 and a two-hundred day moving average price of $0.19.

Integrated BioPharma (OTCMKTS:INBP) last announced its earnings results on Friday, September 25th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $9.80 million during the quarter. Integrated BioPharma had a negative net margin of 6.48% and a negative return on equity of 14.78%.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc (OTCMKTS:INBP) is a healthcare products company engaged in the manufacture and distribution of vitamins, nutritional supplements, herbal products, and pharmaceutical products. Its activities are focused on products intended to support general health and wellness.

The company has historically served the U.S. market through a combination of proprietary products, contract manufacturing, and wholesale distribution activities. Its manufacturing capabilities have included a range of product formats, such as capsules, tablets, softgels, liquids, powders, creams, and lotions, depending on customer and product requirements.

Integrated BioPharma’s operations have included the development, production, and distribution of health-related consumer products for its own brands and other businesses.